{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:06:49Z","timestamp":1770041209842,"version":"3.49.0"},"reference-count":98,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["PIE-201420E109"],"award-info":[{"award-number":["PIE-201420E109"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00703"],"award-info":[{"award-number":["PI14\/00703"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["RTC-2015-3786-1, RTC-2015-3846-1"],"award-info":[{"award-number":["RTC-2015-3786-1, RTC-2015-3846-1"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01509","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T04:16:48Z","timestamp":1510201008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?"],"prefix":"10.3389","volume":"8","author":[{"given":"Silvia","family":"Santamaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Garcia-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01597","article-title":"PD-1, PD-L1, and PD-1\/PD-L1 blockade: have we found the key to unleash the antitumor immune response?","author":"Xu-Monette","year":"2017","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1053\/j.seminoncol.2015.02.015","article-title":"Immune checkpoint protein inhibition for cancer: preclinical justification for CTLA-4 and PD-1 blockade and new combinations","volume":"42","author":"Baksh","year":"2015","journal-title":"Semin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.coi.2017.01.003","article-title":"Targeting NK-cell checkpoints for cancer immunotherapy","volume":"45","author":"Muntasell","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood-2013-08-519199","article-title":"Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies","volume":"123","author":"Kohrt","year":"2014","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ccell.2017.03.002","article-title":"Harnessing the immunotherapy revolution for the treatment of childhood cancers","volume":"31","author":"Majzner","year":"2017","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01804","article-title":"New strategies using antibody combinations to increase cancer treatment effectiveness","author":"Corraliza","year":"2017","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/1074-7613(94)90037-X","article-title":"The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype","volume":"1","author":"Morrison","year":"1994","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.273.5272.242","article-title":"Long-term lymphohematopoietic reconstitution by a single CD34-low\/negative hematopoietic stem cell","volume":"273","author":"Osawa","year":"1996","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature04372","article-title":"Generation of a functional mammary gland from a single stem cell","volume":"439","author":"Shackleton","year":"2006","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature04496","article-title":"Purification and unique properties of mammary epithelial stem cells","volume":"439","author":"Stingl","year":"2006","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.cell.2015.05.041","article-title":"Embryonic origin of postnatal neural stem cells","volume":"161","author":"Fuentealba","year":"2015","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev.neuro.051508.135600","article-title":"The glial nature of embryonic and adult neural stem cells","volume":"32","author":"Kriegstein","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/nature04956","article-title":"Asymmetric and symmetric stem-cell divisions in development and cancer","volume":"441","author":"Morrison","year":"2006","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1096\/fj.11-200782","article-title":"Intrinsic cues and hormones control mouse mammary epithelial tree size","volume":"26","author":"Diaz-Guerra","year":"2012","journal-title":"FASEB J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","article-title":"A restricted cell population propagates glioblastoma growth after chemotherapy","volume":"488","author":"Chen","year":"2012","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nature11344","article-title":"Defining the mode of tumour growth by clonal analysis","volume":"488","author":"Driessens","year":"2012","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.1224676","article-title":"Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas","volume":"337","author":"Schepers","year":"2012","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/stem.1296","article-title":"Intravital imaging of cancer stem cell plasticity in mammary tumors","volume":"31","author":"Zomer","year":"2013","journal-title":"Stem Cells"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/annonc\/mdl074","article-title":"Tumour stem cell-targeted treatment: elimination or differentiation","volume":"17","author":"Massard","year":"2006","journal-title":"Ann Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nrc1232","article-title":"Applying the principles of stem-cell biology to cancer","volume":"3","author":"Pardal","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4149\/neo_2014_061","article-title":"Surface markers of hepatocellular cancer stem cells and their clinical potential","volume":"61","author":"Feng","year":"2014","journal-title":"Neoplasma"},{"key":"B29","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3892\/or_00000314","article-title":"More than 45% of A549 and H446 cells are cancer initiating cells: evidence from cloning and tumorigenic analyses","volume":"21","author":"Meng","year":"2009","journal-title":"Oncol Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Collins","year":"2005","journal-title":"Cancer Res"},{"key":"B32","first-page":"12084","article-title":"Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1177\/548.6520","article-title":"Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells","volume":"96","author":"Zhang","year":"2010","journal-title":"Tumori"},{"key":"B34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","article-title":"Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma","volume":"104","author":"Prince","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1182\/blood-2003-09-3064","article-title":"Characterization of clonogenic multiple myeloma cells","volume":"103","author":"Matsui","year":"2004","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","article-title":"A tumorigenic subpopulation with stem cell properties in melanomas","volume":"65","author":"Fang","year":"2005","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/jcb.22350","article-title":"Cancer stem cells: cell culture, markers, and targets for new therapies","volume":"108","author":"Gilbert","year":"2009","journal-title":"J Cell Biochem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ctrv.2009.03.002","article-title":"How powerful is CD133 as a cancer stem cell marker in brain tumors?","volume":"35","author":"Cheng","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbrc.2008.08.107","article-title":"MIR-451 and Imatinib mesylate inhibit tumor growth of glioblastoma stem cells","volume":"376","author":"Gal","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1756-9966-29-113","article-title":"Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells","volume":"29","author":"Niu","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2176\/nmc.49.146","article-title":"Brain tumor stem cells from an adenoid glioblastoma multiforme","volume":"49","author":"Oka","year":"2009","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O\u2019Brien","year":"2007","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1073\/pnas.0915135107","article-title":"Cancer stem cells from colorectal cancer-derived cell lines","volume":"107","author":"Yeung","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1073\/pnas.0703478104","article-title":"Phenotypic characterization of human colorectal cancer stem cells","volume":"104","author":"Dalerba","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1158\/0008-5472.CAN-11-0241","article-title":"Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche","volume":"71","author":"Grange","year":"2011","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/107327480401100216","article-title":"Considerations for targeting malignant stem cells in leukemia","volume":"11","author":"Guzman","year":"2004","journal-title":"Cancer Control"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/hep.22141","article-title":"Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice","volume":"47","author":"Rountree","year":"2008","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2008.01.013","article-title":"Significance of CD90+ cancer stem cells in human liver cancer","volume":"13","author":"Yang","year":"2008","journal-title":"Cancer Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","article-title":"Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells","volume":"67","author":"Ho","year":"2007","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ"},{"key":"B52","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","article-title":"Identification of bronchioalveolar stem cells in normal lung and lung cancer","volume":"121","author":"Kim","year":"2005","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/modpathol.2010.68","article-title":"Progenitor stem cell marker expression by pulmonary carcinomas","volume":"23","author":"Moreira","year":"2010","journal-title":"Mod Pathol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/modpathol.3800720","article-title":"Increased expression of stem cell markers in malignant melanoma","volume":"20","author":"Klein","year":"2007","journal-title":"Mod Pathol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","article-title":"Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance","volume":"68","author":"Matsui","year":"2008","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1111\/j.1349-7006.2010.01672.x","article-title":"Identification and characterization of cancer stem cells in ovarian yolk sac tumors","volume":"101","author":"Suzuki","year":"2010","journal-title":"Cancer Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Gao","year":"2010","journal-title":"Oncogene"},{"key":"B58","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem cell pathways contribute to clinical chemoresistance in ovarian cancer","volume":"18","author":"Steg","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1158\/1078-0432.CCR-08-0584","article-title":"Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer","volume":"14","author":"Simeone","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1167\/iovs.08-2356","article-title":"Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry","volume":"50","author":"Balla","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/jid.2011.317","article-title":"Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinoma","volume":"132","author":"Patel","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.stem.2008.02.009","article-title":"Module map of stem cell genes guides creation of epithelial cancer stem cells","volume":"2","author":"Wong","year":"2008","journal-title":"Cell Stem Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3389\/fimmu.2017.01001","article-title":"Therapeutic antibodies against intracellular tumor antigens","volume":"8","author":"Trenevska","year":"2017","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.lfs.2014.10.013","article-title":"CD123 and its potential clinical application in leukemias","volume":"122","author":"Liu","year":"2015","journal-title":"Life Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","article-title":"Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells","volume":"5","author":"Jin","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells","volume":"7","author":"Kikushige","year":"2010","journal-title":"Cell Stem Cell"},{"key":"B70","unstructured":"2017"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.neuroscience.2010.04.058","article-title":"Characterization of novel monoclonal antibodies able to identify neurogenic niches and arrest neurosphere proliferation and differentiation","volume":"169","author":"Del Valle","year":"2010","journal-title":"Neuroscience"},{"key":"B72","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.scr.2014.11.006","article-title":"Detection of mouse endogenous type B astrocytes migrating towards brain lesions","volume":"14","author":"Elvira","year":"2015","journal-title":"Stem Cell Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.4103\/1673-5374.165266","article-title":"Insights of the brain damage response using antibodies identifying surface antigens on neural stem cells and neuroblasts","volume":"10","author":"Santamaria","year":"2015","journal-title":"Neural Regen Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.addr.2011.03.005","article-title":"Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions","volume":"64","author":"Alkilany","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"B75","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1152\/physrev.00035.2005","article-title":"Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins","volume":"86","author":"Deeley","year":"2006","journal-title":"Physiol Rev"},{"key":"B76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2017.03.008","article-title":"Combination of chemotherapy and cancer stem cell targeting agents: preclinical and clinical studies","volume":"396","author":"Li","year":"2017","journal-title":"Cancer Lett"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-10-2817","article-title":"Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations","volume":"71","author":"Fischer","year":"2011","journal-title":"Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1158\/1541-7786.MCR-10-0457","article-title":"Notch1 inhibition alters the CD44hi\/CD24lo population and reduces the formation of brain metastases from breast cancer","volume":"9","author":"McGowan","year":"2011","journal-title":"Mol Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/sj.onc.1208511","article-title":"Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations","volume":"24","author":"He","year":"2005","journal-title":"Oncogene"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1158\/1535-7163.MCT-08-0573","article-title":"An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer","volume":"7","author":"Feldmann","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"B81","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00280-016-3213-5","article-title":"Use of retinoic acid\/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells","volume":"79","author":"Moreb","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.exphem.2017.04.007","article-title":"Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation","volume":"52","author":"van Gils","year":"2017","journal-title":"Exp Hematol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1038\/onc.2016.467","article-title":"Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCzeta pathway","volume":"36","author":"Wu","year":"2017","journal-title":"Oncogene"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2741\/4143","article-title":"Cancer stem cell in the progression and therapy of pancreatic cancer","volume":"18","author":"Xu","year":"2013","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/intimm\/dxu095","article-title":"Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies","volume":"27","author":"Philips","year":"2015","journal-title":"Int Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2015.00012","article-title":"Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges","volume":"6","author":"Vela","year":"2015","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/onc.2015.133","article-title":"TGF-beta1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7\/CCL21-mediated chemotaxis","volume":"35","author":"Pang","year":"2016","journal-title":"Oncogene"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.3892\/mmr.2017.6534","article-title":"Chemokine (CC motif) ligand 21\/CC chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial-mesenchymal transition via the extracellular signal-regulated kinase signaling pathway","volume":"15","author":"Zhong","year":"2017","journal-title":"Mol Med Rep"},{"key":"B90","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12894-016-0181-3","article-title":"miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7","volume":"16","author":"Zhou","year":"2016","journal-title":"BMC Urol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-017-0592-0","article-title":"Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cells","volume":"16","author":"Boyle","year":"2017","journal-title":"Mol Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e52426","DOI":"10.1371\/journal.pone.0052426","article-title":"CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma","volume":"7","author":"Lun","year":"2012","journal-title":"PLoS One"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e990767","DOI":"10.4161\/2162402X.2014.990767","article-title":"Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells","volume":"4","author":"Lu","year":"2015","journal-title":"Oncoimmunology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3892\/ijo.2016.3812","article-title":"CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer","volume":"50","author":"Tu","year":"2017","journal-title":"Int J Oncol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e0130808","DOI":"10.1371\/journal.pone.0130808","article-title":"Identification and characterization of CXCR4-positive gastric cancer stem cells","volume":"10","author":"Fujita","year":"2015","journal-title":"PLoS One"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/stem.1407","article-title":"CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis","volume":"31","author":"Gassenmaier","year":"2013","journal-title":"Stem Cells"},{"key":"B97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","article-title":"Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity","volume":"154","author":"Chaffer","year":"2013","journal-title":"Cell"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2012.02.008","article-title":"Slug and Sox9 cooperatively determine the mammary stem cell state","volume":"148","author":"Guo","year":"2012","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01509\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T21:58:09Z","timestamp":1570312689000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01509\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":98,"alternative-id":["10.3389\/fimmu.2017.01509"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01509","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"article-number":"1509"}}